Lamperti, MassimoRomero García, Carolina SoledadGuarracino, FabioCammarota, GiammariaVetrugno, LuigiTufegdzic, BorisLozsan, FranciscoMacías Frías, Juan JoséDuma, AndreasBock, Matthiaset al.2025-11-212025-11-212025Lamperti, M., Romero, C. S., Guarracino, F., Cammarota, G., Vetrugno, L., Tufegdzic, B., Lozsan, F., Macias Frias, J. J., Duma, A., Bock, M., Ruetzler, K., Mulero, S., Reuter, D. A., La Via, L., Rauch, S., Sorbello, M., & Afshari, A. (2025). Reply to: Sodium-glucose cotransporter-2 inhibitors and the significant risk of euglycaemic keto-acidosis in cardiac surgery. European Journal of Anaesthesiology, 42(7), 668-669. https://doi.org/10.1097/EJA.00000000000021880265-0215https://hdl.handle.net/11268/16498engReply to: sodium-glucose cotransporter-2 inhibitors and the significant risk of euglycaemic keto-acidosis in cardiac surgeryjournal article10.1097/EJA.0000000000002188embargoed accessCiencias médicasCirugíaFarmacologíaGoal 3: Ensure healthy lives and promote well-being for all at all agesGoal 9: Build resilient infrastructure, promote sustainable industrialization and foster innovationGoal 12: Ensure sustainable consumption and production patterns